Relationship Between Immunity and Metabolism in Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer. ( RIMEC )
Clinical trial NCT04808817 · UNKNOWN
Trial details
- NCT number
- NCT04808817
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-10
- Primary completion
- 2024-04-09
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.